← All indications
Dyspepsia
Impaired digestion, especially after eating.
Drugs by status
Approved for this indication (16)
Phase 4 trials (55)
- flupentixol
- mannitol
- levofloxacin
- metronidazole
- aluminum
- buspirone
- procaine benzylpenicillin
- berberine
- bifidobacterium animalis
- bismuth
- Bismuth Subcitrate Potassium
- sucralfate
- cromoglicic acid
- folic acid
- furazolidone
- lactulose
- simethicone
- famotidine
- amoxicillin
- itropride
- linaclotide
- ursodeoxycholic acid
- aluminum hydroxide
- saccharomyces boulardii
- scopolamine
- rikkunshito
- articaine
- pantoprazole
- rabeprazole
- banhasasim-tang
- +25 more
Phase 3 trials (27)
- amitriptyline
- cinitapride
- ketotifen
- doxycycline
- dlbs2411
- gabapentin
- escitalopram
- metoclopramide
- naproxen
- nimesulide
- nitazoxanide
- lidocaine
- rifabutin
- rifaximin
- tannic acid
- schinus terebinthifolius
- Acotiamide
- calcium alginate
- bifidobacterium bifidum
- lonicera japonica
- nortriptyline
- tegaserod
- trifluoperazine
- Lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus delbrueckii
- da-5212
Phase 2 trials (24)
- maltodextrin
- 13c-uracil
- Casopitant
- dexloxiglumide
- cannabidiol
- finafloxacin
- l-glutamine
- secretin human
- iw-9179
- tradipitant
- nigella sativa
- prucalopride succinate
- secretrol
- exendin (9-39)
- technetium tc-99m sulfur colloid kit
- yh12852
- ondansetron
- bifidobacterium longum
- spirulina platensis
- aolanti weipang
- lactobacillus casei
- kenodeoxycholic acid
- lactobacillus rhamnosus
- maytenus senegalensis
Phase 1 trials (8)
Other trials (30)
- montelukast
- propofol
- spirulina
- oxytocin
- capsaicin
- fiber
- ginger
- magnesium oxide
- citrulline
- puyuanhewei
- corticorelin ovine triflutate
- mastiha
- pepsin
- fentanyl
- yili chang qing pro-abb
- melilotus officinalis
- algeldrate
- Allantoin
- midazolam
- sodium bicarbonate
- tea
- venlafaxine
- desipramine
- hyoscyamine
- deanxit
- qingre liangkou ningxin fang
- xiangsha liujunzi
- dolichos lalalab linne
- zuojinwan
- da-9701
Organizations
Organization Involved with Phase 4 Indications (58)
- Takeda
- AstraZeneca
- Novartis
- Dong-A Pharmaceutical
- Materia Medica Holding
- Huazhong University of Science and Technology
- Akdeniz University
- Chulalongkorn University
- China Academy of Chinese Medical Sciences
- Georgetown University
- Hanyang University
- Inje University
- Katholieke Universiteit Leuven
- Korea Health Industry Development Institute
- Korea University
- Korean College of Helicobacter and Upper Gastrointestinal Research
- Kyung Hee University
- Mahidol University
- Lotung Poh-Ai Hospital
- Osaka City University
- Pamukkale University
- Seoul National University
- Seoul Veterans Hospital
- University Hospital Koge
- University of Malaya
- University of Southern Denmark
- Yonsei University
- Mayo Clinic
- Chinese University of Hong Kong
- Daegu Catholic University
- +28 more
Organization Involved with Phase 3 Indications (46)
- Zeria Pharmaceutical
- Eisai
- McNeil
- Knoll
- Forest Laboratories
- Astellas
- Pfizer
- Atlantia Food Clinical Trials
- BioGaia AB
- Korea United Pharm. Inc.
- Lallemand SAS
- Daewoong Pharmaceutical Co. LTD.
- IlDong Pharmaceutical Co Ltd
- Otsuka
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- United States Army
- United States Air Force
- Maastricht University
- Baylor University
- Dartmouth University
- Federal University of Rio Grande do Sul
- Hospital Infantil Cândido Fontoura
- McMaster University
- Northwestern University
- Tanta University
- Thammasat University
- Tohoku University
- University of Kansas
- University of Maryland
- University of Adelaide
- +16 more
Organization Involved with Phase 2 Indications (22)
- Ironwood Pharmaceuticals
- Biopolis S.L.
- Effexus Pharmaceutical
- GlaxoSmithKline
- MerLion Pharmaceuticals GmbH
- Qingfeng Pharmaceutical Group
- Casa Espirita Terra de Ismael
- Hospital Universitario Central de Asturias
- Indian Council of Medical Research
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Fujian Medical University
- King Abdullah Medical City
- Xiyuan Hospital
- University of Sao Paulo
- University of Ribeirao Preto
- Kawasaki Medical University
- Department of Veteran Affairs
- Saudi Arabia Army
- Yuhan Pharmaceutical Company
- Government of Spain
- Tsumura and Company
- Institute of Advanced Study in Science and Technology
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (30)
- Merck
- Inner Mongolia Yili Industrial Group Co., Ltd
- Lama Medical Care s.r.o.
- ZonMw: The Netherlands Organisation for Health Research and Development
- National Center for Research Resources (NCRR)
- Helse Fonna
- Carle Foundation Hospital
- Carle Physician Group
- Centro Regional para el Estudio de las Enfermedades Digestivas
- Harvard University
- Temple University
- Lund University
- Medical University of Lodz
- Ochsner Health System
- Ohio State University
- Radboud University
- University of Rochester
- Utrecht University
- University of Bergen
- Virginia Commonwealth University
- Aga Khan University
- Shandong University
- Medical University of South Carolina
- Chung-Ang University
- Chengdu University of Traditional Chinese Medicines
- Gastroenterology Hepatology Centrum THALION, Bratislava
- Carle Health Care Incorporated
- Haugesund Hospital
- Naturex SA
- Advanced Breath Diagnostics, LLC